Articles on psychedelic-assisted therapy, clinical documentation, and AI privacy.
February 26, 2026 · 11 min read
Psychedelic-assisted therapy is the most rigorously studied new paradigm in mental health treatment in decades. This post maps the evidence base every PAT practitioner should know — from MDMA and psilocybin trials to therapeutic modalities, outcome measures, and the documentation gap MycenAI is designed to fill.
Read more →February 26, 2026 · 10 min read
The psychedelic experience is not the therapy. Integration — making meaning, consolidating insights, and translating experiences into lasting change — is what determines outcomes. Here is how to document it.
Read more →February 26, 2026 · 10 min read
The quality of AI-generated clinical documentation depends entirely on the prompt. This guide introduces the MycenAI Clinical Prompt Library and explains how structured, PAT-specific prompt templates produce documentation that reflects the actual complexity of psychedelic-assisted therapy.
Read more →February 26, 2026 · 9 min read
Psychedelic-assisted therapy generates more documentation than standard talk therapy, across more phases, with higher privacy stakes. Here is what AI-assisted documentation looks like for PAT practitioners.
Read more →